4/20/2022China Commercial Health Insurance Opportunities

4/19/202234 HK-Listed Chinese Biopharma Firms Saw Sharp Revenue Growth in 2021 ...

4/18/2022VectorBuilder to Build $500M Gene Therapy Manufacturing Facility in Ch...

4/16/2022Opportunities and Challenges in China for Developing Oncology Drugs fo...

4/15/2022NMPA Issues the Guidelines for Pharmacovigilance Inspections

4/14/2022PhIIC: Chinese Retail Biologics Sales Led by Anti-tumor Drugs in 2021

4/13/2022China Meheco to Distribute Ascletis's Ritonavir Tablets in Mainland Ch...

4/12/2022Chinese Pharma Foreign Trade Up 1.9% in 2021 with Sharply Surging West...

4/12/2022NMPA Issues the Measures for Drug Annual Reports

4/11/2022Decentralized CRO Science 37 Expands in the Asia-Pacific including Chi...

4/11/2022Clinical Development Strategies for Western Biotech Companies in China...

4/10/2022Market Segmentation Snapshot of Chinese Retail Drug Market 2019-2021

4/10/2022Chinese Pharma Profits Fell Sharply in the First Two Months of 2022

4/8/2022Recent Executive Moves

4/8/2022China Views Pay-For-Delay Deal as Antitrust Offence, Lawyer Cautions (...

4/7/2022The Chinese Pharma CMO Market to Reach $13B in 2030, Predicts Roots An...

4/7/2022CDMO Asymchem Completes Expansion of  Chinese Manufactuing Facilitie...

4/6/2022Novartis, BeiGene's Tislelizumab Gets EMA Review in Esophageal, Lung C...

4/6/2022AstraZeneca Licenses Harbour BioMed's CLDN18.2xCD3 Bispecific Antibody...

4/6/2022Everest Med Enters into an MOU for Partnership with CR Pharma for its ...

4/5/2022Chinese VMS OTC Market Up 8.4% in 2021, Driven by Higher Health Awaren...

4/5/2022Investment into Chinese Biotech Falls Abruptly as U.S. Steps Up Scrut...

4/5/2022The Chinese Supreme People's Court Released New Interpretation on Seve...

4/3/2022Daiichi Sankyo Disposes Chinese Rights of Cravit Formulations and Loca...

4/1/2022CASI Pharma Added to SEC List of Firms Facing Possible U.S. Delisting

4/1/2022CDE Issues the Technical Guidelines for Pharmaceutical Research and Ev...

4/1/2022Recent Executive Moves

3/31/2022CDE Solicits Comments on the Inspection Checkpoints of Drug MAHs (Draf...

3/31/2022Financial-related Company News Digest (March 2022)

3/31/2022Recent Executive Moves

Page:79/367 Total number of articles:10986: [First][<<] [77] [78] [79] [80] [81] [>>] [End]